HSBC Holdings plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on April 2, 2026, reports a transaction by a person discharging managerial responsibilities (PDMR) under the UK version of the EU Market Abuse Regulation. The filing concerns David Lindberg, Chief Executive of HSBC UK Bank plc, and relates to share awards granted on March 31, 2026, under the HSBC Share Plan 2011.
Key Financial Metrics
The filing does not provide consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics for HSBC Holdings plc. It details specific share transaction values:
- Total Acquisition Value: £11,014,532.58 (1,034,617 shares at an aggregated price of £10.646).
- Total Disposal Value: £735,501.11 (60,473 shares sold at £12.162 to cover tax liabilities).
- Net Shares Vested: 68,191 shares.
- Deferred Shares Awarded: 905,953 shares.
Material Changes
This filing represents an initial notification of a specific executive compensation event rather than a period-over-period financial performance comparison. The transaction involves the buy-out of forfeited awards from a previous employer, with awards based on the share price on December 8, 2025 (£10.646).
Outlook, Risks, and Unusual Items
Management Commentary: The awards consist of immediately vested shares (subject to a 12-month retention period) and deferred shares vesting in annual tranches from March 2027 to March 2032 (also subject to a 12-month retention period upon vesting).
Risks/Contingencies: The filing notes that 60,473 shares were immediately sold to satisfy Income Tax and Social Security liabilities. No other risks or contingencies are disclosed in this specific notification.
Key Facts for Investor Verification
- Verify the total number of shares awarded to David Lindberg (1,034,617) and the split between immediate and deferred vesting.
- Confirm the share price used for the award (£10.646) versus the price used for the tax disposal (£12.162).
- Review the vesting schedule for the 905,953 deferred shares, which extends to March 2032.
- Note that this filing is a regulatory disclosure of a PDMR transaction and does not contain the company's quarterly or annual financial results.